Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 15;526(7573):361-70.
doi: 10.1038/nature15819.

Patient-centric trials for therapeutic development in precision oncology

Andrew V Biankin  1   2   3   4 , Steven Piantadosi  5 , Simon J Hollingsworth  6
Affiliations
Free article
Review

Patient-centric trials for therapeutic development in precision oncology

Andrew V Biankin et al. Nature. .
Free article

Abstract

An enhanced understanding of the molecular pathology of disease gained from genomic studies is facilitating the development of treatments that target discrete molecular subclasses of tumours. Considerable associated challenges include how to advance and implement targeted drug-development strategies. Precision medicine centres on delivering the most appropriate therapy to a patient on the basis of clinical and molecular features of their disease. The development of therapeutic agents that target molecular mechanisms is driving innovation in clinical-trial strategies. Although progress has been made, modifications to existing core paradigms in oncology drug development will be required to realize fully the promise of precision medicine.

PubMed Disclaimer

References

    1. Curr Opin Oncol. 2015 May;27(3):250-7 - PubMed
    1. J Thorac Oncol. 2013 Apr;8(4):436-42 - PubMed
    1. N Engl J Med. 2012 Feb 23;366(8):707-14 - PubMed
    1. Nat Rev Drug Discov. 2013 May;12(5):358-69 - PubMed
    1. N Engl J Med. 2010 Jun 24;362(25):2380-8 - PubMed